These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities. Younes IE; Syler L; Hamed A Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988 [TBL] [Abstract][Full Text] [Related]
23. Clone wars--the emergence of neoplastic blood-cell clones with aging. Abkowitz JL N Engl J Med; 2014 Dec; 371(26):2523-5. PubMed ID: 25426835 [No Abstract] [Full Text] [Related]
24. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. Yoshizato T; Dumitriu B; Hosokawa K; Makishima H; Yoshida K; Townsley D; Sato-Otsubo A; Sato Y; Liu D; Suzuki H; Wu CO; Shiraishi Y; Clemente MJ; Kataoka K; Shiozawa Y; Okuno Y; Chiba K; Tanaka H; Nagata Y; Katagiri T; Kon A; Sanada M; Scheinberg P; Miyano S; Maciejewski JP; Nakao S; Young NS; Ogawa S N Engl J Med; 2015 Jul; 373(1):35-47. PubMed ID: 26132940 [TBL] [Abstract][Full Text] [Related]
25. [Importance of clonal hematopoiesis for hematologic neoplasms]. Götze KS; Lengerke C Inn Med (Heidelb); 2022 Nov; 63(11):1107-1114. PubMed ID: 36125513 [TBL] [Abstract][Full Text] [Related]
26. Clonal hematopoiesis of indeterminate potential and cardiovascular disease. Saadatagah S; Ballantyne CM Transl Res; 2023 May; 255():152-158. PubMed ID: 36067904 [TBL] [Abstract][Full Text] [Related]
28. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk. Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE; Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531 [TBL] [Abstract][Full Text] [Related]
29. Clonal hematopoiesis and associated diseases: A review of recent findings. Asada S; Kitamura T Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684 [TBL] [Abstract][Full Text] [Related]
30. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease. Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415 [TBL] [Abstract][Full Text] [Related]
34. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200 [TBL] [Abstract][Full Text] [Related]
35. Clinical, Mutational, and Transcriptomic Characteristics in Elderly Korean Individuals With Clonal Hematopoiesis Driver Mutations. Moon I; Kong MG; Ji YS; Kim SH; Park SK; Suh J; Jang MA Ann Lab Med; 2023 Mar; 43(2):145-152. PubMed ID: 36281508 [TBL] [Abstract][Full Text] [Related]